MARÍA LUZ HERNÁNDEZ GÁLVEZ-rekin lankidetzan egindako argitalpenak (41)

2017

  1. Altered striatal endocannabinoid signaling in a transgenic mouse model of spinocerebellar ataxia type-3

    PLoS ONE, Vol. 12, Núm. 4

  2. Modeling Neurodegenerative Disorders for Developing Cannabinoid-Based Neuroprotective Therapies

    Methods in Enzymology (Academic Press Inc.), pp. 175-198

2016

  1. Dysregulation of the endocannabinoid signaling system in the cerebellum and brainstem in a transgenic mouse model of spinocerebellar ataxia type-3

    Neuroscience, Vol. 339, pp. 191-209

2014

  1. Cannabinoids and the brain: New hopes for new therapies

    Cannabinoids (John Wiley and Sons Ltd), pp. 175-218

  2. Changes in CB1 and CB2 receptors in the post-mortem cerebellum of humans affected by spinocerebellar ataxias

    British Journal of Pharmacology, Vol. 171, Núm. 6, pp. 1472-1489

  3. Endocannabinoid-hydrolysing enzymes in the post-mortem cerebellum of humans affected by hereditary autosomal dominant ataxias

    Pathobiology, Vol. 81, Núm. 3, pp. 149-159

2010

  1. Cannabinoid-dopamine interaction in the pathophysiology and treatment of CNS disorders

    CNS Neuroscience and Therapeutics, Vol. 16, Núm. 3

2008

  1. Cannabinoid signaling system: does it play a function in cell proliferation and migration, neuritic elongation and guidance and synaptogenesis during brain ontogenesis?

    Cell adhesion & migration, Vol. 2, Núm. 4, pp. 246-248

  2. Colocalization of CB1 receptors with L1 and GAP-43 in forebrain white matter regions during fetal rat brain development: Evidence for a role of these receptors in axonal growth and guidance

    Neuroscience, Vol. 153, Núm. 3, pp. 687-699

2007

  1. The activation of cannabinoid receptors during early postnatal development reduces the expression of cell adhesion molecule L1 in the rat brain

    Brain Research, Vol. 1145, Núm. 1, pp. 48-55

2004

  1. Behavioral and molecular changes elicited by acute administration of SR141716 to Δ 9 -tetrahydrocannabinol-tolerant rats: An experimental model of cannabinoid abstinence

    Drug and Alcohol Dependence, Vol. 74, Núm. 2, pp. 159-170

  2. Cannabinoids and gene expression during brain development

    Neurotoxicity Research, Vol. 6, Núm. 5, pp. 389-401

2003

  1. Prenatal cannabinoid and gene expression for neural adhesion molecule L1 in the fetal rat brain.

    Brain research. Developmental brain research, Vol. 147, Núm. 1-2, pp. 201-207

2002

  1. Exposure to cannabinoids in the development of endogenous cannabinoid system

    Neurotoxicity Research, Vol. 4, Núm. 4, pp. 363-372

2000

  1. Cannabinoid CB1 receptors colocalize with tyrosine hydroxylase in cultured fetal mesencephalic neurons and their activation increases the levels of this enzyme

    Brain Research, Vol. 857, Núm. 1-2, pp. 56-65

  2. The endogenous cannabinoid system and brain development

    Trends in Neurosciences, Vol. 23, Núm. 1, pp. 14-20

1999

  1. Role of endocannabinoids in brain development

    Life Sciences, Vol. 65, Núm. 6-7, pp. 725-736

1998

  1. Localization of mRNA expression and activation of signal transduction mechanisms for cannabinoid receptor in rat brain during fetal development

    Development, Vol. 125, Núm. 16, pp. 3179-3188

1997

  1. Atypical location of cannabinoid receptors in white matter areas during rat brain development

    Synapse, Vol. 26, Núm. 3, pp. 317-323

  2. Δ9-tetrahydrocannabinol increases activity of tyrosine hydroxylase in cultured fetal mesencephalic neurons

    Journal of Molecular Neuroscience, Vol. 8, Núm. 2, pp. 83-91